XML 75 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Financial Assets & Liabilities (Tables)
9 Months Ended
Sep. 30, 2023
Investments, All Other Investments [Abstract]  
Financial assets and financial liabilities measured at fair value on a recurring basis
The following table presents the company’s financial assets and financial liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022.
Fair Value
Hierarchy
Level
At September 30, 2023At December 31, 2022
(Dollars in millions)
Assets (5)
Liabilities (6)
Assets (5)
Liabilities (6)
Cash equivalents: (1)
Time deposits and certificates of deposit (2)
2$3,765 N/A$3,712 N/A
Money market funds1212 N/A 306 N/A
Total cash equivalents$3,977 N/A$4,018 N/A
Equity investments1N/A— N/A
Debt securities-current (2)(3)
23,721 N/A852 N/A
Debt securities-noncurrent (2)(4)
2,333 N/A31 N/A
Derivatives designated as hedging instruments:
Interest rate contracts2579 336 
Foreign exchange contracts2420 185 184 674 
Derivatives not designated as hedging instruments:
Foreign exchange contracts212 45 42 16 
Equity contracts255 49 
Total$8,164 $864 $5,179 $1,034 
(1)Included within cash and cash equivalents in the Consolidated Balance Sheet.
(2)Available-for-sale debt securities with carrying values that approximate fair value.
(3)Term deposits and U.S. treasury bills that are reported within marketable securities in the Consolidated Balance Sheet. The September 30, 2023 balance includes partial proceeds from the first quarter 2023 debt issuances. See note 12, "Borrowings," for additional information.
(4)Includes immaterial activity related to private company investments reported within investments and sundry assets in the Consolidated Balance Sheet.
(5)The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Balance Sheet at September 30, 2023 were $431 million and $1 million, respectively, and at December 31, 2022 were $271 million and $7 million, respectively.
(6)The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Balance Sheet at September 30, 2023 were $171 million and $693 million, respectively, and at December 31, 2022 were $546 million and $488 million, respectively.
N/A – not applicable